DBL PHOSPHATE IONS 0.67 Molar/20mL Injection Australia - engelsk - Department of Health (Therapeutic Goods Administration)

dbl phosphate ions 0.67 molar/20ml injection

pfizer australia pty ltd - dibasic sodium phosphate dodecahydrate, quantity: 192 mg/ml; monobasic potassium phosphate, quantity: 17.4 mg/ml - injection, concentrated - excipient ingredients: water for injections - indications as at 30 april 2004: treatment of severe hypophosphataemia (serum levels less than 0.3 mmol/l) and other degrees of hypophosphataemia when oral therapy is not possible. the cause of hypophosphataemia should be identified and treated.

ACCUSOL 35 potassium 4 mmol/L haemofiltration solution for intravenous injection Australia - engelsk - Department of Health (Therapeutic Goods Administration)

accusol 35 potassium 4 mmol/l haemofiltration solution for intravenous injection

aa-med pty ltd - calcium chloride dihydrate, quantity: 1.286 g; magnesium chloride hexahydrate, quantity: 0.51 g; sodium chloride, quantity: 28.2 g; glucose monohydrate, quantity: 5.512 g (equivalent: glucose, qty 4.987 g); potassium chloride, quantity: 1.492 g - injection, solution - excipient ingredients: water for injections; dibasic sodium phosphate dihydrate; dilute hydrochloric acid - a continuous renal replacement therapy (crrt) replacement fluid used in intensive care units for the treatment of acute kidney injury.

ACCUSOL 35 potassium 2 mmol/L haemofiltration solution for intravenous injection Australia - engelsk - Department of Health (Therapeutic Goods Administration)

accusol 35 potassium 2 mmol/l haemofiltration solution for intravenous injection

aa-med pty ltd - magnesium chloride hexahydrate, quantity: 0.51 g; calcium chloride dihydrate, quantity: 1.286 g; sodium chloride, quantity: 28.2 g; glucose monohydrate, quantity: 5.512 g (equivalent: glucose, qty 4.987 g); potassium chloride, quantity: 0.746 g - injection, solution - excipient ingredients: water for injections; dibasic sodium phosphate dihydrate; dilute hydrochloric acid - a continuous renal replacement therapy (crrt) replacement fluid used in intensive care units for the treatment of acute kidney injury.

DBL® Sodium Phosphate and Potassium Phosphate Concentrated Injection New Zealand - engelsk - Medsafe (Medicines Safety Authority)

dbl® sodium phosphate and potassium phosphate concentrated injection

hospira nz ltd - dibasic sodium phosphate dodecahydrate 0.192 g/ml; monobasic potassium phosphate 0.0174 g/ml - solution for injection - active: dibasic sodium phosphate dodecahydrate 0.192 g/ml monobasic potassium phosphate 0.0174 g/ml excipient: water for injection

SLOW RELEASE CMPK BOLUS calcium magnesium phosphorus and potassium tablet USA - engelsk - NLM (National Library of Medicine)

slow release cmpk bolus calcium magnesium phosphorus and potassium tablet

pegasus laboratories, inc. - dibasic calcium phosphate dihydrate (unii: o7tsz97gep) (calcium phosphate, dibasic, anhydrous - unii:l11k75p92j) - calcium phosphate, dibasic, anhydrous 10.3 g

DIACOL sodium phosphate 1.5g tablet bottle Australia - engelsk - Department of Health (Therapeutic Goods Administration)

diacol sodium phosphate 1.5g tablet bottle

fresenius kabi australia pty ltd - dibasic sodium phosphate,monobasic sodium phosphate monohydrate -

K PHOS NEUTRAL- sodium phosphate, dibasic, anhydrous, potassium phosphate, monobasic, and sodium phosphate, monobasic, monohydra USA - engelsk - NLM (National Library of Medicine)

k phos neutral- sodium phosphate, dibasic, anhydrous, potassium phosphate, monobasic, and sodium phosphate, monobasic, monohydra

beach products, inc. - sodium phosphate, dibasic, anhydrous (unii: 22ado53m6f) (phosphate ion - unii:nk08v8k8hr, sodium cation - unii:lyr4m0nh37), potassium phosphate, monobasic (unii: 4j9fj0hl51) (phosphate ion - unii:nk08v8k8hr, potassium cation - unii:295o53k152), sodium phosphate, monobasic, monohydrate (unii: 593yog76rn) (phosphate ion - unii:nk08v8k8hr, sodium cation - unii:lyr4m0nh37) - sodium phosphate, dibasic, anhydrous 852 mg - k-phos® neutral increases urinary phosphate and pyrophosphate. as a phosphorus supplement, each tablet supplies 25% of the u.s. recommended daily allowance (u.s.rda) of phosphorus for adul t s and children over 4 years of age. this product is contraindicated in patients with infected phosphate stones, in patients with severely impaired renal function (less than 30% of normal) and in the presence of hyperphosphatemia.

PHOSPHO-TRIN 250 NEUTRAL- sodium phosphate, dibasic, anhydrous, potassium phosphate, monobasic, and sodium phosphate, monobasic, USA - engelsk - NLM (National Library of Medicine)

phospho-trin 250 neutral- sodium phosphate, dibasic, anhydrous, potassium phosphate, monobasic, and sodium phosphate, monobasic,

patrin pharma, inc. - sodium phosphate, dibasic, anhydrous (unii: 22ado53m6f) (phosphate ion - unii:nk08v8k8hr), potassium phosphate, monobasic (unii: 4j9fj0hl51) (phosphate ion - unii:nk08v8k8hr), sodium phosphate, monobasic, monohydrate (unii: 593yog76rn) (phosphate ion - unii:nk08v8k8hr) - sodium phosphate, dibasic, anhydrous 852 mg - phospho-trin™ 250 neutral increases urinary phosphate and pyrophosphate. as a phosphorus supplement, each tablet supplies 25% of the u.s. recommended daily allowance (u.s. rda) of phosphorus for adults and children over 4 years of age. this product is contraindicated in patients with infected phosphate stones, in patients with severely impaired renal function (less than 30% of normal) and in the presence of hyperphosphatemia.

DBL SODIUM PHOSPHATE AND POTASSIUM PHOSPHATE CONCENTRATED INJECTION Australia - engelsk - Department of Health (Therapeutic Goods Administration)

dbl sodium phosphate and potassium phosphate concentrated injection

hospira australia pty ltd - potassium phosphate - monobasic; sodium phosphate - dibasic dodecahydrate -